当前位置: X-MOL 学术J. Am. Acad. Dermatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A provider global assessment quality measure for clinical practice for inflammatory skin disorders
Journal of the American Academy of Dermatology ( IF 13.8 ) Pub Date : 2018-09-20 , DOI: 10.1016/j.jaad.2018.09.017
Alice Gottlieb , Nicole Salame , April W. Armstrong , Joseph F. Merola , Sylvia Parra , Junko Takeshita , Suephy C. Chen , John Latella , Marta Van Beek

In our evolving health care system, dermatologists are increasingly being asked to prove the value of care they provide to patients with severe skin diseases. Current quality measures for inflammatory dermatoses have limited validity and feasibility. Through collaboration and a modified Delphi process, International Dermatology Outcome Measures and the American Academy of Dermatology sought to reach consensus on a valid and feasible provider-assessed global disease severity metric to be incorporated into a quality measure for inflammatory dermatoses. To inform the modified Delphi process, a review of the literature was performed, and data were collected on current provider-assessed global disease severity metrics. After literature review, 36 members of International Dermatology Outcome Measures and the American Academy of Dermatology participated in the modified Delphi process to reach consensus on features of the metric. Psoriasis, atopic dermatitis, and acne achieved overwhelming consensus for inflammatory dermatoses that could be measured in a global disease severity metric. Consensus was also reached on the use of a 5-point ordinal scale with descriptors provided through referenced electronic platforms. Expert development of quality measures incorporating this metric and its inclusion in data collection platforms are critical to enabling dermatologists to prove the value of care provided to patients with severe inflammatory dermatoses.



中文翻译:

针对炎症性皮肤病临床实践的提供者全球评估质量衡量

在我们不断发展的卫生保健系统中,越来越多地要求皮肤科医生证明他们为重症皮肤病患者提供的护理价值。当前用于炎性皮肤病的质量措施具有有限的有效性和可行性。通过合作和改进的Delphi流程,国际皮肤病学成果度量标准和美国皮肤病学学会寻求就有效且可行的提供商评估的全球疾病严重性度量标准达成共识,以将其纳入炎症性皮肤病的质量度量标准中。为了告知改进的Delphi流程,对文献进行了回顾,并收集了有关当前提供者评估的全球疾病严重性指标的数据。经过文献审查,国际皮肤病学成果度量标准和美国皮肤病学学会的36名成员参加了改进的Delphi流程,以就度量标准的特征达成共识。银屑病,特应性皮炎和痤疮在炎症性皮肤病方面达到了压倒性的共识,可以用整体疾病严重性指标进行测量。在使用5点序量表和通过参考电子平台提供的描述符时也达成了共识。结合此指标并将其包含在数据收集平台中的质量度量的专家开发对于使皮肤科医生证明向严重炎症性皮肤病患者提供护理的价值至关重要。和痤疮在炎症性皮肤病方面达成了压倒性共识,可以用全球疾病严重性指标进行衡量。在使用5点序量表和通过参考电子平台提供的描述符时也达成了共识。结合此指标并将其包含在数据收集平台中的质量度量的专家开发对于使皮肤科医生证明向严重炎症性皮肤病患者提供护理的价值至关重要。和痤疮在炎症性皮肤病方面达成了压倒性共识,可以用全球疾病严重性指标进行衡量。在使用5点序量表以及通过参考电子平台提供的描述符时也达成了共识。结合此指标并将其包含在数据收集平台中的质量度量的专家开发对于使皮肤科医生证明向严重炎症性皮肤病患者提供护理的价值至关重要。

更新日期:2018-09-20
down
wechat
bug